Skip to main content
BAX
NYSE Life Sciences

Baxter Q1 Revenue Jumps 3%, Beats Estimates; Adjusted EPS Also Tops Forecasts

Tom Rudovsky · Reported by Reuters
More coverage: Medical Instrument Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$17.75
Mkt Cap
$8.725B
52W Low
$15.73
52W High
$32.68
52W Position info
13% above low
Off High info
46% below high
Rel. Volume info
1.6× avg
Market data snapshot near publication time

BAX is trading near its 52-week low of $15.73 (13% above the low).

Summary

Baxter International reported strong first-quarter results, with revenue rising 3% to $2.70 billion, surpassing analyst expectations of $2.62 billion. The company also beat on the bottom line, posting adjusted diluted EPS of $0.37 against a consensus of $0.31. While organic revenue saw a slight 1% decline due to lower U.S. sales and segment headwinds, the overall beat on both top and bottom lines is a positive signal for the company's operational performance. This earnings release also reiterated the full-year 2026 adjusted EPS guidance of $1.85 to $2.05, which was previously announced. Traders will likely react positively to the Q1 beats, indicating better-than-expected execution despite some underlying challenges.

At the time of this announcement, BAX was trading at $17.75 on NYSE in the Life Sciences sector, with a market capitalization of approximately $8.7B. The 52-week trading range was $15.73 to $32.68. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

BAX - Latest Insights

BAX
Oct 29, 2026, 4:31 PM EDT
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $22.94
Real-time Price: $25.93 info
Change: +$2.99 (+13%) info
Market Cap: $13.41B info
BAX
Oct 29, 2026, 8:06 AM EDT
Source: dpa-AFX
Importance Score:
7
Price at Filing: $26.00
Real-time Price: $25.93 info
Change: -$0.075 (-0.29%) info
Market Cap: $13.41B info
BAX
Oct 29, 2026, 7:18 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $26.74
Real-time Price: $25.93 info
Change: -$0.815 (-3%) info
Market Cap: $13.41B info
BAX
Oct 29, 2026, 7:15 AM EDT
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $26.50
Real-time Price: $25.93 info
Change: -$0.575 (-2%) info
Market Cap: $13.41B info
BAX
Aug 19, 2026, 8:07 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $26.20
Real-time Price: $25.93 info
Change: -$0.275 (-1%) info
Market Cap: $13.41B info